Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...

C. difficile is a leading cause of hospital-acquired infections, with strains increasingly exhibiting antibiotic resistance. Current treatments often involve broad-spectrum antibiotics ...

Meanwhile, A new report from the Health Protection Surveillance Centre (HPSC) found that 605 cases of C diff were reported ...

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously ...

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative ...

Investigators at Pennsylvania State University have described a novel approach to combat Clostridioides difficile infection ...

Fzata, Inc. announces the execution of a clinical trial agreement with the National Institutes of Health (NIH) to sponsor a ...

Scientists develop a synthetic microbiome therapy to fight C. difficile infections offering a safer, targeted alternative ...

The team said their findings could lead to the development of new probiotic strategies for humans to treat C. difficile infections as an alternative to antibiotics and conventional fecal ...